{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:26:07Z","timestamp":1765423567469,"version":"3.40.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacig.2025.100411","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T19:50:59Z","timestamp":1737229859000},"page":"100411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis"],"prefix":"10.1016","volume":"4","author":[{"given":"Twan","family":"Sia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leeon","family":"Bacchus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100411_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/alr.23090","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis \u2013 2023","volume":"13","author":"Wise","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jacig.2025.100411_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iac.2019.09.009","article-title":"Mechanisms of subcutaneous and sublingual aeroallergen immunotherapy","volume":"40","author":"Koml\u00f3si","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jacig.2025.100411_bib3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(21)00438-4","article-title":"Current and future status of JAK inhibitors","volume":"398","author":"McLornan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2025.100411_bib4","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1080\/21645515.2018.1508624","article-title":"Anti-CD20 monoclonal antibodies: reviewing a revolution","volume":"14","author":"Casan","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jacig.2025.100411_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13601-019-0285-4","article-title":"Contraindications to immunotherapy: a global approach","volume":"9","author":"Pitsios","year":"2019","journal-title":"Clin Transl Allergy"},{"author":"Pongracic","key":"10.1016\/j.jacig.2025.100411_bib6"},{"key":"10.1016\/j.jacig.2025.100411_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178563","article-title":"Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma","volume":"12","author":"Aguilar-Pimentel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacig.2025.100411_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15586\/aei.v50i6.495","article-title":"Omalizumab and allergen immunotherapy for respiratory allergies","volume":"50","author":"De Filippo","year":"2022","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jacig.2025.100411_bib9","doi-asserted-by":"crossref","first-page":"00639","DOI":"10.1183\/23120541.00639-2022","article-title":"Adding a biologic to allergen immunotherapy increases treatment efficacy","volume":"9","author":"Bo\u017cek","year":"2023","journal-title":"ERJ Open Res"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T19:43:00Z","timestamp":1746906180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829325000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2772829325000128"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100411","relation":{},"ISSN":["2772-8293"],"issn-type":[{"type":"print","value":"2772-8293"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100411"}}